Microglioma

Microglioma is a rare brain tumor that develops from microglial cells. Microglia are a type of glial cell that performs immune and support functions in the central nervous system.

Microgliomas most often occur in children and adolescents, although they can also be diagnosed in adults. The tumor is usually located in the brainstem, cerebellum or thalamus. Clinical manifestations depend on the location and include headache, vomiting, visual and motor impairment.

The diagnosis of microglioma is made based on MRI and histological examination. Treatment includes surgical removal of the tumor, radiation therapy, and in some cases chemotherapy. The prognosis depends on the histological type of microglioma and the degree of radicality of the treatment. Low-grade forms with adequate treatment can provide long-term survival.

Microglioma, or otherwise microglia, is a malignant tumor that occurs in the central nervous system. Consists of glial precursors microglial cells. Like most brain tumors, their detection rate has increased significantly over the past few decades. According to statistics, it is registered in young people aged 20 to 30 years. You can notice the growth trend of such tumors over the past 5 years. It occurs in only 0.1–2% of all reported malignant brain lesions. As the tumor progresses, five to twenty-five percent of the cranial lobes are affected. Most often, malignant tumors occur in the frontal lobe, less often in the temporal, frontotemporal or parietal lobe of the brain in children. The disease usually manifests itself with acute headaches, am